Abstract
The results of this report provide evidence that insulin-like growth factor-1 binding proteins (IGFBPs) in human sera are differentially regulated as a result of severe burn injury. Using the ligand binding technique,125I-IGF-1 visualizes 5 different protein bands corresponding to those previously reported for IGFBP-1 to 4 with apparent sizes of 23–42 kd in serum samples prepared from severely burned patients and healthy individuals. The level of IGFBP-3 was significantly decreased within 3–5 days of injury and remained depressed for up to 20 days post injury. The average level of this binding protein reached its lowest value within 3–5 days of the injury (3.8±1.48% relative to day 0–1 value, n=4, p<0.001). Serum samples from 3 to 4 patients showed no recovery within 20 days post injury and the level of IGFBP-3 remained significantly depressed (p<0.01). In contrast, the levels of IGFBP-2 and IGFBP-4 increased 2 and 3 fold in the same serum samples within 3–5 days of the burn injury, respectively. This increase returns to normal (day 0–1 value) within 7–10 days for IGFBP-2, but the level of IGFBP-4 remained elevated 4 fold relative to the day 0–1 (p<0.01). However, the abundance of IGFBP-1 in these serum samples was not significantly altered by the burn injury. By controlling for protein loading, these apparent alterations of IGFBPs in the sera of burned patients were not due to hemodilution. Similarly, significant reductions in IGFBP-3 were not likely due to IGFBP-3 specific protease activity in the sera of burn patients since incubation of sera from burn patients and normal individuals at 37° C did not alter the pattern of IGFBPs in sera obtained from normal individuals. Of interest, the level of IGF-1 protein in these samples was also markedly reduced following severe burn injury similar to IGFBP-3. The results of this study suggest that a marked reduction of serum IGF-1 seen in burn patients is associated with a significant reduction of IGFBP-3, a major IGF-1 binding protein in human serum.
Similar content being viewed by others
References
Salmon WD, Daughaday WH: A hormonally growth factor which stimulates sulfate incorporation by cartilagein vitro. J Lab Clin Med 1957, 49: 825–836
Svoboda ME, Van Wyk JJ, Klapper DG, Fellows RE, Grissom FE, Schlueter RJ: Purification of somatomedin-C from human plasma: Chemical and biological properties, partial sequence analysis and relationship to other somatomedins. Biochemistry 1980; 19: 790–797
Clemmons DR, Van Wyk JJ: Somatomedins: Physiological control and effects on cell proliferation. In: R Baserga (ed.) Handbook of Experimental Pharmacology. Springer-Verlag, New York, 1981, pp 161–164
Schoenle E, Zapf J, Humbel RE, Froesch ER: Insulin-like growth factor-1 stimulates growth in hypophysectomized rats. Nature 1982; 296: 252–253
Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC: Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 1988; 2: 1176–1185
Burch WM, Correa J, Shively JE, Powell DR: The 25-kilodalton insulin-like growth factor binding protein inhibits both basal and IGF-1 mediated growth of chick embryo pelvic cartilagein vitro. J Clin Endocrinol Metab 1990; 70: 173–180
Baxter RC, Martin JL, Berniac VA: High molecular weight insulin-like growth factor binding protein complex: Purification and properties of the acid labile subunit from human serum. J Biol Chem 1989; 264: 11843–11848
Martin JL, Baxter RC: Insulin-like growth factor binding proteins from human plasma. Purification and characterization. J Biol Chem 1986; 261: 8754–8760
Hardouin S, Hossenlopp HP, Segovia B, Seurin D, Portolan G, Lassarre C, Binoux M: Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity: Circulation form in man. Eur J Biochem 1987; 170: 121–132
Crum RL, Dominic W, Housbrough JF, Shackford SR, Brown MR: Cardiovascular and neurohumoral responses following burn injury. Arch Surg 1990; 125: 1065–1069
Tredget EE, Yu YM: The metabolic effects of thermal injury. World J Surg 1992; 16: 68–79
Wilmore DW, Moylan JA, Bristow BF, Mason AD, Pruitt BA Jr: Anabolic effect of human growth hormone and high caloric feeding following thermal injury. Surg Gynecol Obs 1974; 138: 875–884
Rutan RL, Herndon DN: Growth delays in post-burn pediatric patients. Arch Surg 1990; 125: 392–395
Moller S, Jensen M, Svensson P, Skakkeback NE: Insulin-like growth factor-1 (IGF-1) in burn patients. Burns 1991; 17: 279–281
Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL: Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990; 212: 424–429
Strock LL, Singh H, Abdulla A, Miller JA, Herndon DN: The effect of insulin-like growth factor-1 on post-burn hypermetabolism. Surgery 1990; 108: 161–164
Tredget EE, Shakowsky HA, Taerum TV, Moysa GL, Alton JDM: The role of inhalation injury in burn trauma: A Canadian Experience. Ann Surg 1990; 212: 720–727
Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titeation of the binding proteins and competitive binding studies. Anal Biochem 1986; 154: 138–143
Daughaday WH, Mariz IK, Blethen SL: Inhibition of excess bound somatomedin to membrane receptor and immunobinding sites. A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 1980; 51: 781–788
Breier BH, Gallaher BW, Gluckman PD: Radioimmunoassay for insulin-like growth factor-1: Solutions to some potential problems and pitfalls. J Endocrinol 1991; 128: 347–357
Abribat T, Brazeau P, Davinon I, Garrel DR: Insulin-like growth factor-1 levels in severely burned patients: Effects of time post injury, age of patient and severity of burn. Clin Endocrinol 1993; 39: 583–589
Davies SC, Wass JAH, Ross RJM, Cotterill AM, Buchanan CR, Coulson VJ, Holly JMP: The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 1991; 130: 469–473
Liu F, Powell DR, Hintz RL: Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 1990; 70: 620–628
Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfield RG: Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 1990; 71: 806–816
Borsi L, Rosenfield RG, Liu F, Hintz RL: Somatomedin peptide distribution and somatomedin-binding protein content in cord plasma: Comparison to normal and hypopituitary plasma. J Clin Endocrinol Metab 1982; 54: 223–228
Wood WI, Cachianes G, Henzed WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Boxter RC: Cloning and expression of the growth hormone-dependent insulin-like growth factor binding protein. Mol Endocrinol 1988; 2: 1176–1185
Zapt J, Hauri C, Waldvogel M, Futo E, Hiasler H, Binz K, Guler HP, Schmidt C, Froesch ER: Recombinant human insulin-like growth factor-1 induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA 1989; 86: 3813–3817
Neely FK, Rosenfield RG: Insulin-like growth factors reduce IGF-1 binding protein-4 concentration and stimulate IGFBP-3 independent of IGF receptors in human fibroblasts and epidermal cells. Endocrinology 1992; 130: 985–993
Murphy LJ, Seneviratne C, Ballejo G, Cropze F, Kennedy TG: Identification and characterization of a rat decidual insulin-like growth factor binding protein cDNA. Mol Endocrinol 1990; 4: 329–336
Davis SR, Hodgkinson SC, Moore LG, Gluckman PD: Improved estimates of clearance of125I-labeled insulin-like growth factor-1 carrier protein complexes from blood plasma of sheep. J Endocrinol 1989; 123: 469–475
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghahary, A., Fu, S., Shen, Y.J. et al. Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem 135, 171–180 (1994). https://doi.org/10.1007/BF00926520
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00926520